Biofrontera Inc.
BFRI
DELAYED 1 MONTH

9 insider filings · Latest: Jul 28, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 28, 2026Jul 29 9:47 PMHermann LuebbertDirector, CEO & Chairman
Option Exercise
62,500—62,500(D)

View →

Jul 28, 2026Jul 29 9:44 PMEugene Frederick LefflerChief Financial Officer
Option Exercise
31,250—31,250(D)

View →

Mar 4, 2026Mar 7 2:33 AMKevin Daniel WeberDirector
Grant/Award
20,000$0.9020,000(D)

View →

Mar 5, 2026Mar 7 2:31 AMHermann LuebbertDirector, CEO & Chairman
Option Exercise
137,500—0(D)

View →

Mar 4, 2026Mar 7 2:31 AMHermann LuebbertDirector, CEO & Chairman
Grant/Award
250,000$0.90125,000(D)

View →

Mar 5, 2026Mar 7 2:30 AMEugene Frederick LefflerChief Financial Officer
Option Exercise
87,500—0(D)

View →

Mar 4, 2026Mar 7 2:30 AMEugene Frederick LefflerChief Financial Officer
Grant/Award
125,000$0.9062,500(D)

View →

Mar 4, 2026Mar 7 2:29 AMHeikki LanckrietDirector
Grant/Award
20,000$0.9020,000(D)

View →

Mar 4, 2026Mar 7 2:28 AMBeth J. HoffmanDirector
Grant/Award
20,000$0.9020,000(D)

View →

Mar 4, 2026Mar 7 2:26 AMGeorge Patrick JonesChief Commercial Officer
Grant/Award
100,000$0.9050,000(D)

View →

Mar 4, 2026Mar 7 2:25 AMBORER JOHN J IIIDirector
Grant/Award
20,000$0.9020,000(D)

View →